Action OLK OLINK HOLDING AB
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Olink Holding AB

Actions

OLK

US6807101000

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 09/07/2024 		Varia. 5j. Varia. 1 janv.
26,08 USD +0,31 % Graphique intraday de Olink Holding AB 0,00 % +3,70 %
10/07 Thermo Fisher Scientific finalise l'acquisition d'Olink MT
10/07 Thermo Fisher Scientific Inc. (NYSE:TMO) a finalisé l'acquisition d'Olink Holding AB (publ) (NasdaqGM:OLK) auprès de Summa Equity AB et d'autres. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Notice to attend the Extra General Meeting of Olink Holding AB (publ)
Olink Holding AB(NasdaqGM:OLK) dropped from S&P Global BMI Index
Thermo Fisher Scientific Completes Acquisition of Olink
Olink Holding AB(NasdaqGM:OLK) dropped from NASDAQ Composite Index
Thermo Fisher Scientific Inc. completed the acquisition of Olink Holding AB from Summa Equity AB and others.
Olink Holding Receives UK Approval for Thermo Fisher's $26 per Share Tender Offer
Olink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo Fisher
Report from the Extra General Meeting of Olink Holding AB (publ) on 5 July 2024
Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery
Notice to attend the Extra General Meeting of Olink Holding AB (publ)
Notice to attend the Extra General Meeting of Olink Holding AB (publ)
Olink Target 48 Immune Surveillance Panel, the Next Frontier in Immune Biomarker Profiling with Absolute Confidence
Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence
Olink® Target 48 Immune Surveillance Panel ? the Next Frontier in Immune Biomarker Profiling with Absolute Confidence
Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis
Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis
Researchers Use Olink®? Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis
Olink Holding's Q1 Net Loss Widens, Revenue Rises
Olink reports first quarter 2024 financial results
Olink Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action OLK
  4. Actualités Olink Holding AB
  5. Autres langues